CAMBRIDGE, Mass., Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Cyclerion Therapeutics, Inc. today announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology ( &#34;MIT&#34; ) , securing the intellectual property that will serve as the cornerstone of its strategic ...

CYCN

<p>剑桥，马萨诸塞州，2025 年 9 月 23 日（GLOBE NEWSWIRE）-- Cyclerion Therapeutics, Inc. 今天宣布已与麻省理工学院（"MIT"）签署了一项许可协议，获得将作为其战略基石的知识产权</p>

Cyclerion 宣布作为一家神经精神公司进行转型重组